True Blue (TBI) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $16 price target. Company is leveraged to rising ISM new orders index and could see more demand following Hurricane Sandy.
Watson Pharmaceuticals (WPI) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $103 price target. Company offers growth at a reasonable price.
STOCK COMMENTS / EPS CHANGESLinkedIn (LNKD - Get Report) numbers boosted at Citi. Shares of LNKD now seen reaching $135, according to Citigroup. Estimates also upped, as the company is gaining market share. Buy rating.
Priceline.com (PCLN) numbers raised at Goldman. Shares of PCLN now seen reaching $770, according to Goldman Sachs. Estimates also increased, as the company is realizing higher bookings growth. Buy rating.Pfizer (PFE) estimates, target reduced at BMO. PFE estimates were cut through 2013, BMO Capital said. Company is being hurt by the stronger dollar. Outperform rating and new $29 price target. Starbucks (SBUX) estimates, target raised at BofA/Merrill. Shares of SBUX now seen reaching $60, according to Bank of America/Merrill Lynch. Estimates also increased, as new products are driving growth. Buy rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.